miRDx™
BKV KitBKV Diagnostics Using miRNA Biomarkers
The BK virus is a type of polyomavirus that most people first become infected with during childhood. The initial infection is usually asymptomatic, and the virus can remain dormant in the cells of the kidneys or urinary tract for life. For individuals with a healthy immune system, the BK virus acquired in childhood typically does not cause any problems.
The global incidence of kidney failure and transplants is rising. Kidney transplant patients receive immunosuppressive drugs to prevent organ rejection, which can lead to BKV nephropathy caused by the proliferation of the BK virus. However, in immunocompromised or immunosuppressed patients, the virus can reactivate due to weakened immunity.
Liquid Biopsy
Advantage of miRNA Biomarker
Non-invasive
Quick, Easy, Repetitive
Convenient
Disease Monitoring
Enabling
Early Diagnosis
Sample Stability
Advantage of miRNA Biomarker
HB miRDx™
BKV KitBK viral DNA detection is usually time consuming, and although various techniques are developed to reduce the reaction time, Real time PCR and quantitative validation still require some time. Whereas, detecting BK virus using miRNA has high accuracy and sensitivity which allows to detect BK virus 1.5 to 2 month earlier than the viral DNA detection technology.
※ Clinical Effectiveness (Confirmation) Evaluation Final Report - Kyung Hee University Hospital at Gangdong
HB miRDx™ is one of three miRNA detection technologies (RT-qPCR based) in the world. This technique possesses multiplexing capabilities and allows for accurate sequencing of PCR products, in addition to boasting high sensitivity and specificity.
해당 제품의 관련한 기술인 HB miRDx™ 페이지로 이동합니다.
Pangyo Silicon Park A-201 35, Pangyo-ro 255beon-gil, Bundang-gu,
Seongnam-si, Gyeonggi-do, Korea, 13486
Business registration number : 135-86-48279
Tel : 1522-7026
Fax : 031-548-2135
E-mail : info@heimbiotek.com